| n/a | | | Investors in AR/VR (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series A), Investors in Sales & CRM (Seed), Investors in AR/VR (Seed), Investors in Analytics (Series A), Investors in SMB Software (Seed), Investors in AI (Series B), Investors in Payments (Seed), Investors in Cloud Infrastructure (Series B), Investors in Analytics (Seed), Investors in Cloud Infrastructure (Series A), Investors in Cloud Infrastructure (Seed), Investors in Payments (Series B), Investors in Enterprise (Series B), Investors in Payments (Series A), Investors in Sales & CRM (Series B), Investors in Sales & CRM (Series A), Investors in SMB Software (Series B), Investors in AI (Seed), Investors in FinTech (Series B), Investors in SMB Software (Series A), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in SaaS (Series B), Investors in Investors who invested in diverse founders (Other Lists), Investors in Analytics (Seed), Investors in AR/VR (Seed), Investors in Enterprise (Series A), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Payments (Seed), Investors in SaaS (Seed), Investors in SMB Software (Seed), Investors in Sales & CRM (Seed), Investors in Analytics (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in Cloud Infrastructure (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in Payments (Series A), Investors in SMB Software (Series A), Investors in SaaS (Series A), Investors in Sales & CRM (Series A), Investors in FinTech (Series B), Investors in AI (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series B), Investors in Cloud Infrastructure (Series B), Investors in Enterprise (Series B), Investors in Sales & CRM (Series B), Investors in SMB Software (Series B), Investors in Payments (Series B), Investors in SaaS (Series B), Investors in Analytics (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Payments (Pre-seed), Investors in Sales & CRM (Pre-seed), Investors in SMB Software (Pre-seed), Investors in Cloud Infrastructure (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in AI (Pre-seed), Investors in FinTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in AR/VR (Pre-seed), Investors in Cloud Infrastructure (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Payments (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in SMB Software (Pre-seed), Investors in Cloud Infrastructure (Seed), Investors in SaaS (Series A), Investors in FinTech (Series A), Investors in Sales & CRM (Pre-seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed) +78 |
| n/a | | | Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed) +12 |
| n/a | | | Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B) +15 |
| n/a | | | Investors in GovTech (Seed), Investors in Hardware (Seed), Investors in Developer Tools (Series B), Investors in Developer Tools (Series A), Investors in Robotics (Seed), Investors in Developer Tools (Seed), Investors in Cloud Infrastructure (Series B), Investors in Cloud Infrastructure (Series A), Investors in GovTech (Series B), Investors in GovTech (Series A), Investors in Hardware (Series B), Investors in Cloud Infrastructure (Seed), Investors in Hardware (Series A), Investors in Enterprise (Series B), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Space (Series A), Investors in Space (Series B), Investors in Space (Seed), Investors in SaaS (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Seed), Investors in Developer Tools (Seed), Investors in Developer Tools (Seed), Investors in Developer Tools (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in GovTech (Seed), Investors in GovTech (Seed), Investors in New York City (Other Lists), Investors in Hardware (Seed), Investors in Hardware (Seed), Investors in Enterprise (Seed), Investors in Robotics (Seed), Investors in Hardware (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Robotics (Seed), Investors in SaaS (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in Robotics (Seed), Investors in Space (Seed), Investors in Cloud Infrastructure (Series A), Investors in Cloud Infrastructure (Series A), Investors in Developer Tools (Series A), Investors in Developer Tools (Series A), Investors in Enterprise (Series A), Investors in Cloud Infrastructure (Series A), Investors in Developer Tools (Series A), Investors in Enterprise (Series A), Investors in GovTech (Series A), Investors in Hardware (Series A), Investors in Hardware (Series A), Investors in GovTech (Series A), Investors in Hardware (Series A), Investors in Enterprise (Series A), Investors in GovTech (Series A), Investors in Robotics (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Space (Series A), Investors in Robotics (Series A), Investors in Space (Series A), Investors in SaaS (Series A), Investors in Space (Series A), Investors in Robotics (Series A), Investors in Cloud Infrastructure (Series B), Investors in Hardware (Series B), Investors in Cloud Infrastructure (Series B), Investors in Developer Tools (Series B), Investors in Developer Tools (Series B), Investors in GovTech (Series B), Investors in Enterprise (Series B), Investors in Hardware (Series B), Investors in Cloud Infrastructure (Series B), Investors in GovTech (Series B), Investors in GovTech (Series B), Investors in Enterprise (Series B), Investors in Developer Tools (Series B), Investors in Enterprise (Series B), Investors in Hardware (Series B), Investors in SaaS (Series B), Investors in Space (Series B), Investors in Space (Series B), Investors in Robotics (Series B), Investors in Robotics (Series B), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in Future of Work (Series B), Investors in Robotics (Series B), Investors in Future of Work (Series A), Investors in Future of Work (Seed), Investors in Space (Series B), Investors in GovTech (Seed), Investors in Cloud Infrastructure (Seed), Investors in SaaS (Series A), Investors in Enterprise (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed) +97 |
| n/a | | | Investors in AI (Series B), Investors in Data Services (Series B), Investors in GovTech (Series B), Investors in GovTech (Series A), Investors in Data Services (Series A), Investors in Insurance (Series B), Investors in Enterprise (Series B), Investors in Marketplaces (Series B), Investors in Real Estate/PropTech (Series B), Investors in Real Estate/PropTech (Series A), Investors in Social Networks (Series B), Investors in Insurance (Series A), Investors in FinTech (Series B), Investors in AI (Series A), Investors in Marketplaces (Series A), Investors in SaaS (Series B), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in AI (Series A), Investors in Data Services (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in GovTech (Series A), Investors in Insurance (Series A), Investors in Marketplaces (Series A), Investors in SaaS (Series A), Investors in Social Networks (Series A), Investors in Real Estate/PropTech (Series A), Investors in AI (Series B), Investors in Data Services (Series B), Investors in FinTech (Series B), Investors in Enterprise (Series B), Investors in GovTech (Series B), Investors in Marketplaces (Series B), Investors in Insurance (Series B), Investors in SaaS (Series B), Investors in Real Estate/PropTech (Series B), Investors in Social Networks (Series B), Investors in Social Networks (Series A), Investors in SaaS (Series A), Investors in FinTech (Series A) +36 |
| n/a | | | Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed) +8 |
| n/a | | | |
| n/a | | | Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A) +17 |
| n/a | | | Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B) +14 |
| n/a | | | |
| n/a | | | |
| n/a | | | Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B) +10 |
| n/a | | | |
| n/a | | Investors in United States | Investors in Local Services (Seed), Investors in Social Commerce (Seed), Investors in Consumer Health (Series B), Investors in SMB Software (Seed), Investors in Payments (Seed), Investors in E-commerce (Series B), Investors in Consumer Health (Series A), Investors in Local Services (Series B), Investors in Local Services (Series A), Investors in E-commerce (Series A), Investors in Payments (Series B), Investors in Marketplaces (Series B), Investors in Payments (Series A), Investors in Social Commerce (Series B), Investors in Social Commerce (Series A), Investors in SMB Software (Series B), Investors in SMB Software (Series A), Investors in FinTech (Series B), Investors in Consumer Health (Seed), Investors in Marketplaces (Series A), Investors in E-commerce (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Seed), Investors in Marketplaces (Seed) +22 |
| n/a | | | Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B) +13 |
| n/a | | | |
| n/a | | | Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Diverse Investors (Other Lists), Investors in Female Investors (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series B), Investors in BioTech (Series B) +7 |
| n/a | | | Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A) +9 |
| n/a | | | Investors in Advertising (Series B), Investors in Advertising (Series A), Investors in Enterprise (Series B), Investors in Social Networks (Series B), Investors in Enterprise (Series A), Investors in Advertising (Series A), Investors in Enterprise (Series A), Investors in Social Networks (Series A), Investors in Advertising (Series B), Investors in Enterprise (Series B), Investors in Social Networks (Series B), Investors in Boston / New England (Other Lists), Investors in Social Networks (Series A) +9 |